Delivery Order SPE2DE23D0008-SPE2D626F41BS

Allergan USA Inc., a subsidiary of AbbVie Inc., was awarded a $2,400 fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain division on January 22, 2026, for Natrelle Inspira SSM 520cc breast implants. The contract, which carries an ultimate completion date of January 26, 2026, represents a child order issued against one of Allergan's larger Indefinite Delivery Vehicle contracts established with DLA Troop Support Medical. This award was made without a set-aside designation, reflecting Allergan's status as a sole-source provider of these specialized medical devices. The place of performance is listed as Irvine, California.

The delivery order falls under Allergan's broader $13.5 million IDV for Natrelle breast implants and surgical devices, which was established on December 8, 2022, and includes a one-year base period with four one-year option periods. These contracts support reconstructive and aesthetic surgical procedures across Department of Defense treatment facilities, including military hospitals, clinics, and research centers. The fixed-price contract structure with economic price adjustment provision enables DLA to procure specialized implant products on an as-needed basis while maintaining cost predictability and ensuring timely availability of critical surgical supplies for military personnel and eligible beneficiaries.